Published in:
Open Access
01-02-2011 | Poster presentation
Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
Authors:
C Ertmer, H Van Aken, H Wulf, P Friederich, C Mahl, F Bepperling, M Westphal, W Gogarten
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
Hydroxyethyl starch (HES) solutions are commonly used for perioperative volume replacement. Whereas older HES specimens tended to accumulate in the plasma and to cause negative effects on haemostasis, more recent products (for example, HES 130/0.4) are characterised by improved pharmacological properties. The present study was designed to compare the efficacy and safety of 10% HES 130/0.4 and 10% HES 200/0.5. …